NCT04044651 Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection Status WITHDRAWN Phase PHASE2/PHASE3
NCT04042805 Sintilimab Combined With Lenvatinib in Local Advanced Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2
NCT04039607 A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE3
NCT04035876 Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplant Status UNKNOWN Phase PHASE1/PHASE2
NCT04032392 Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells Status UNKNOWN Phase PHASE1
NCT04025567 Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral Status WITHDRAWN Phase PHASE2
NCT04025437 Neoadjuvant Radiotherapy for HCC Involving Type I PVTT Status UNKNOWN Phase PHASE2/PHASE3
NCT04021056 Observational Study on Patients With Hepatocellular Carcinoma (HCC) Status UNKNOWN Phase N/A
NCT04015245 SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy Status COMPLETED Phase PHASE4
NCT04014101 SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2
NCT04012021 EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI Status UNKNOWN Phase NA
NCT04011033 Study of Adoptive Transfer of iNKT Cells Combined With TAE/TACE to Treat Unresectable HCC Status COMPLETED Phase PHASE2
NCT03998033 Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma Status TERMINATED Phase PHASE1
NCT03996681 TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular Carcinoma Status UNKNOWN Phase PHASE4
NCT03990974 Postoperative Antimicrobial Prophylaxis Versus Placebo for Infection Prevention in HCC After Liver Resection Status SUSPENDED Phase PHASE3
NCT03988998 Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma Status UNKNOWN Phase PHASE3